Navigation Links
Diagnostic Imaging - Acquisitions - OTCBB: DIIG
Date:2/8/2008

LAS VEGAS, NV, Feb. 8 /PRNewswire-FirstCall/ - Diagnostic Imaging International Corp. (OTCBB: DIIG) announced today that the Company has begun reviewing a number of diagnostic imaging clinics for acquisition.

Following the Company's business plan Diagnostic Imaging plans to acquire a number of profitable operating clinics as well as open a number of new clinics.

Company management has begun its diligence review on clinics that have been presented for sale to the Company.

Once suitable candidates have been selected and agreements completed the Company will announce the acquisitions as soon as possible.

To find out more about Diagnostic Imaging International Corp. (OTCBB: DIIG), visit our website at http://www.diig.biz or contact the Company directly at 877-331-3444.

About the Company

Diagnostic Imaging International Corp. plans to open, acquire and operate diagnostic imaging clinics in Canada and the United States. The Company's mission is to provide quality MRI services to its clients, delivering convenience, accuracy and the highest standard of care and service. The Company's mandate is to make available, on a timely basis, imaging services for individuals, physicians, workers compensation boards and insurance companies. In addition, DIIC is also interested in CT scan equipment and will examine future opportunities for PET (Positron Emission Tomography) clinics.

This news release includes forward-looking statements that reflect Diagnostic Imaging International Corp. and its subsidiary companies current expectations about its future results, performance, prospects and opportunities. Diagnostic Imaging International Corp. has tried to identify these forward-looking statements by using words and phrases such as "may", "will", "expects", "anticipates", "believes", "intends", "estimates", "should", "typical", "we are confident" or similar expressions. These forward-looking statements are based on information currently available to Diagnostic Imaging International Corp. and are subject to a number of risks, uncertainties and other factors that could cause Diagnostic Imaging International Corp.'s actual results, performance, prospects or opportunities in the remainder of 2008 and beyond to differ materially from those expressed in, or implied by, these forward-looking statements.


'/>"/>
SOURCE Diagnostic Imaging International Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Diagnostic Imaging - New Stock Symbol - OTCBB: DIIG
2. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
3. Physicians Reference Laboratory Announces New Diagnostic for Womens Health
4. Imaging Diagnostic Systems Exhibits at Major Middle East Health Conference
5. New Report Tackles the Changing Landscape for Alzheimers Diagnostics and Treatments
6. Quest Diagnostics Sets New Date to Report Fourth Quarter and Full Year 2007 Results
7. Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA-based Diagnostics for Brain Cancer
8. Quest Diagnostics to Speak at the 26th Annual JPMorgan Healthcare Conference
9. Cinpathogen Provides Clinical Diagnostic Consulting Services to Shanghai Area Hospitals
10. Amic Signs Non-Exclusive License Agreement With Roche Diagnostics for Key Cardiac Marker NT-proBNP
11. Arizona Pain Society and Dr. Robert Barkin, Rush University Medical Center, Present Program on Comprehensive Urine Drug Testing Sponsored by Dominion Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):